Retatrutide

Discover Retatrutide – The Next-Generation Triple Agonist Peptide

Retatrutide is an investigational synthetic peptide designed as a balanced triple agonist of the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. Unlike single or dual agonists, this innovative compound simultaneously activates three key hormonal pathways involved in metabolism, making it a subject of significant interest in obesity, diabetes, and metabolic research.

Key Research Highlights:

•  Triple Receptor Action: Combines GLP-1 and GIP effects (appetite suppression, delayed gastric emptying, improved insulin response) with glucagon receptor activation (increased energy expenditure and fat oxidation).

•  High Purity: Lyophilized powder, typically ≥99% purity (HPLC verified – COA available upon request).

•  Convenient Format: Supplied in a sealed glass vial – ideal for extended research protocols.

•  Long-Acting Profile: Engineered for once-weekly administration in laboratory settings due to its extended half-life.

Researchers are exploring Retatrutide for its potential to support substantial reductions in body weight, improvements in glycaemic control, lipid metabolism, and overall metabolic health through synergistic hormonal signalling.

Product Specifications:

•  Quantity: Various size vials

•  Form: Lyophilized white powder

•  Reconstitution: Use bacteriostatic water (not included unless specified)

•  Storage: Refrigerate after reconstitution; store lyophilized vials in a cool, dry place protected from light

Intended Use: This product is sold by GB-Peptides exclusively for in vitro and laboratory research purposes. It is not intended for human consumption, therapeutic use, or veterinary applications.

Whether you’re studying advanced incretin mimetics or multi-receptor metabolic pathways, Retatrutide offers a premium research tool at the forefront of peptide science.

Research Use Only. Not intended for human or veterinary consumption.